DULUTH, Ga., Oct. 6 Metametrix Clinical Laboratory(http://www.metametrix.com), a leader in nutritional and metabolic testingservices, announced the introduction of the Vitamin K Assay. This latesttesting profile measures a functional marker of Vitamin K, undercarboxylatedosteocalcin. As one of the first commercial laboratories to offer this type ofvitamin K assessment, Metametrix continues its leadership and innovation.
Vitamin K is a fat-soluble vitamin that functions as a co-factor in theproduction of blood coagulation factors (in the liver), osteocalcin (in bone),and matrix Gla-protiens (in cartilage and vessel walls) each resulting in thedeposition of ionic calcium. Vitamin K deficiency lengthens the time requiredfor blood to clot, increases bone fracture risk, and may lead to calcificationof the arteries. Individuals especially at risk for vitamin K deficiencyinclude: those with bone loss or risk of bone loss, those on certain drugtherapies, such as warfarin, and those with cardiovascular disease.
From a simple serum collection, vitamin K testing is the latest in aseries of "Fat-Soluble Vitamin Profiles" from Metametrix and is available asan add-on to its ION and Cardio/ION Profiles. For a complete list ofMetametrix laboratory services and related research, visit the website at:http://www.metametrix.com .
Metametrix Clinical Laboratory has specialized in producing innovative,Next Generation Technologies(SM) for measuring nutritional, metabolic, andtoxic influences on health for the past 24 years. Metametrix is a leader inproviding integrative and functional medicine testing services and educationto healthcare professionals worldwide.
SOURCE Metametrix Clinical Laboratory